Results from the Loire-Ardèche-Drôme-Isère-Puy-de- Dôme (LADIP) Trial on Atrial Flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter

Circulation

Volumn 114, Issue 16, 2006, Pages 1676-1681

  Da Costa, Antoine ^a,l   Thévenin, Jérôme ^a   Roche, Frédéric ^a   Romeyer Bouchard, Cécile ^a   Abdellaoui, Loucif ^b   Messier, Marc ^c   Denis, Lucien ^d   Faure, Emmanuel ^e   Gonthier, Régis ^f   Kruszynski, Georges ^g   Pages, J Marie ^h   Bonijoly, Serge ⁱ   Lamaison, Dominique ^j   Defaye, Pascal ^k   Barthélemy, J Claude ^a   Gouttard, Thierry ⁱ   Isaaz, Karl ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b Firminy Hospital   (France)

^c MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^d Saint Chamond Hospital   (France)

^e Valence Hospital   (France)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g Feurs Hospital   (France)

^h Montbrison Hospital   (France)

ⁱ Annonay Hospital   (France)

^j UNIVERSITÉ CLERMONT AUVERGNE   (France)

^k UNIV GRENOBLE ALPES   (France)

^l HÔPITAL NORD   (France)

more..

Author keywords

Ablation; Arrhythmia; Atrial flutter; Catheter ablation

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; FLECAINIDE;

AGED; ARTICLE; CATHETER ABLATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FATALITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; KAPLAN MEIER METHOD; LOG RANK TEST; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SICK SINUS SYNDROME; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; AMIODARONE; ATRIAL FLUTTER; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33750267704     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.638395     Document Type: Article

References (38)

1. Wellens HJ. Catheter ablation for cardiac arrhythmias. N Engl J Med. 2004;351:1172-1174.
2. Ganz LI, Friedman PL. Supraventricular tachycardia. N Engl J Med. 1995;332:162-173.
3. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW Jr, Stevenson WG, Tomaselli GF, Antman EM, Smith SC Jr, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO Jr, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation. 2003;108:1871-1909.
4. Wellens HJ. Contemporary management of atrial flutter. Circulation. 2002;106:649-652.
5. Campbell WF. Pharmacologic therapy of atrial flutter. J Cardiovasc Electrophysiol. 1996;7:1008-1012.
6. Cosio FG. Should ablation be the first line treatment for supraventricular arrhythmias? Heart. 2005;91:5-6.
7. Natale A, Newby KH, Pisano E, Leonelli F, Fanelli R, Potenza D, Beheiry S, Tomassoni G. Prospective randomized comparison of anti arrhythmic therapy versus first line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. 2000;35:1898-1904.
8. Gilligan DM, Zakaib JS, Amir C, Clemo HF, Dan D, Shepard RK, Wood MA, Ellenbogen KA. Radiofrequency ablation of atrial flutter: is it a definitive cure or simply one step in the management of chronic atrial disease? Pace. 2000;23:553. Abstract.
9. Anselme F, Saoudi N, Poty H, Douillet R, Cribier A. Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. Circulation. 1999;99:534-540.
10. Saoudi N, Poty H, Anselme F, Nair M, Abdelazziz A, Letac B. Evolution of concepts and techniques in radiofrequency catheter ablation for the common type of atrial flutter. In: Saoudi N, Schoels W, El-Scherif N, eds. Atrial Flutter and Fibrillation: From Basic to Clinical Applications. Armonk, NY: Futura Publishing Company Inc; 1998.
11. Calkins H, Canby R, Weiss R, Taylor G, Wells P, Chinitz L, Milstein S, Compton S, Oleson K, Sherfesee L, Onufer J, for the 100W Atakr II Investigator Group. Results of catheter ablation of typical atrial flutter. Am J Cardiol. 2004;94:437-442.
12. Granada J, Uribe W, Chyou PH, Maassen K, Vierkant R, Smith PN, Hayes J, Eaker E, Vidaillet H. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol. 2000;36:2242-2246.
13. Da Costa A, Romeyer C, Faure E, Cerisier A, Isaaz K. Results of radiofrequency ablation of common atrial flutter in elderly patients. Pacing Clin Electrophysiol. 2003;26:1729-1734.
14. Halligan SC, Gersh BJ, Brown RD Jr, Rosales AG, Munger TM, Shen WK, Hammill SC, Friedman PA. The natural history of lone atrial flutter. Ann Intern Med. 2004;140:265-268.
15. Paydak H, Kall JG, Burke MC, Rubenstein D, Kopp DE, Verdino RJ, Wilber DJ. Atrial fibrillation after radiofrequency ablation of type I atrial flutter: time to onset, determinants, and clinical course. Circulation. 1998;98:315-322.
16. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B, for the Canadian Trial of Atrial Fibrillation Investigators. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med. 2000;342:913-920.
17. Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling SF, Pagani FD, Bitar C, Meissner MD, Morady F. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med. 1997;337:1785-1791.
18. Lumer GB, Roy D, Talajic M, Couturier A, Lambert J, Frasure-Smith N, Thibault B, Dubuc M, Gagne P, Nattel S, for the Canadian Trial of Atrial Fibrillation (CTAF) Investigators. Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. Eur Heart J. 2002;23:1050-1056.
19. Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B, for the Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Practical guidelines for clinicians who treat patients with amiodarone. Arch Intern Med. 2000;160:1741-1748.
20. Crijns HJ, Van Gelder IC, Tieleman RG, Brugemann J, De Kam PJ, Gosselink AT, Bink-Boelkens MT, Lie KI. Long term outcome of electrical cardioversion in patients with chronic atrial flutter. Heart. 1997;77:56-61.
21. Poty H, Saoudi N, Nair M, Anselme F, Letac B. Radiofrequency catheter ablation of atrial flutter: further insights into the various types of isthmus block: application to ablation during sinus rhythm. Circulation. 1996;94:3204-3213.
22. Cauchemez B, Haïssaguerre M, Fischer B, Thomas O, Clementy J, Coumel P. Electrophysiological effects of catheter ablation of inferior vena cava-tricuspid annulus isthmus in common atrial flutter. Circulation. 1996;93:284-294.
23. Chen J, De Chillou C, Basiouny T, Sadoul N, Da Silva Filho J, Magnin-Poull I, Messier M, Aliot E. Cavotricuspid isthmus mapping to assess bi-directional block during common atrial flutter radiofrequency ablation. Circulation. 1999;100:2507-2513.
24. Anselme F, Savouré A, Cribier A, Saoudi N. Catheter ablation of typical atrial flutter: a randomized comparison of 2 methods for determining complete bi-directional isthmus block. Circulation. 2001;103:1434-1439.
25. Shah DC, Takahashi A, Jaïs P, Hocini M, Clémenty J, Haïssaguere M. Local electrogram-based criteria of cavo-tricuspid isthmus block. J Cardiovasc Electrophysiol. 1999;10:662-669.
26. Bru P, Duplantier C, Bourrat M, Valy Y, Lorillard R. Resumption of right atrial isthmus conduction following atrial flutter radiofrequency ablation. Pace. 2000;23:1711-2017.
27. Roche F, Gaspoz JM, Pichot V, Costes F, Isaaz K, Ferron C, Roche C, Geyssant A, Lacour JR, Barthelemy JC. Accuracy of an automatic and patient-triggered long-term solid memory ambulatory cardiac event recorder. Am J Cardiol. 1997;80:1095-1098.
28. Roche F, Gaspoz JM, Da Costa A, Isaaz K, Duverney D, Pichot V, Costes F, Lacour JR, Barthelemy JC. Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter. Pacing Clin Electrophysiol. 2002;25:1587-1593.
29. Balaji S, Johnson TB, Sade RM, Case CL, Gillette PC. Management of atrial flutter after the Fontan procedure. J Am Coll Cardiol. 1994;23:1209-1215.
30. Garson A Jr, Bink-Boelkens M, Hesslein PS, Hordof AJ, Keane JF, Neches WH, Porter CJ. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol. 1985;6:871-878.
31. Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KI. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion of atrial fibrillation or atrial flutter. Am J Cardiol. 1991;68:335-341.
32. Gosselink AT, Crijns HJ, Van Gelder IC, Hillige H, Wiesfeld AC, Lie KI. Low-dose of amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or atrial flutter. JAMA. 1992;267:3289-3293.
33. Antman EM, Beamer AD, Cantillon C, McGowan N, Goldman L, Friedman PL. Long term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1988;12:1005-1011.
34. Chun SH, Sager PT, Stevenson WG, Nademanee K, Middlekauff HR, Singh BN. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol. 1995;76:47-50.
35. Elesber AA, Rosales AG, Herges RM, Shen WK, Moon BS, Malouf JF, Ammash NM, Somers V, Hodge DO, Gersh BJ, Hammill SC, Friedman PA. Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly. Eur Heart J. 2006;27:854-860.
36. Da Costa A, Romeyer-Bouchard C, Zarqane-Sliman N, Messier M, Samuel B, Kihel A, Faure E, Isaaz K. Impact of first line radiofrequency ablation in patients with lone atrial flutter on the long-term risk of subsequent atrial fibrillation. Heart. 2005;91:97-98.
37. The AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation Rhythm Management (AFFIRM) study. Circulation. 2004;109:1509-1513.
38. Pedersen OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) substudy. Circulation. 2001;104:292-296.